Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127847571 | 12784757 | 1 | I | 20160826 | 20160916 | 20160927 | 20160927 | EXP | FR-GILEAD-2016-0234085 | GILEAD | 50.00 | YR | A | M | Y | 0.00000 | 20160927 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127847571 | 12784757 | 1 | PS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 1 DF, QD | 16 | DF | Y | 21752 | 1 | DF | TABLET | QD | |||
| 127847571 | 12784757 | 2 | SS | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Oral | 400 MG, BID | 12800 | MG | Y | 0 | 400 | MG | BID | ||||
| 127847571 | 12784757 | 3 | SS | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 160 MG, QD | 2400 | MG | Y | 0 | 160 | MG | QD | ||||
| 127847571 | 12784757 | 4 | C | WELLVONE | ATOVAQUONE | 1 | Oral | UNK | 0 | ||||||||||
| 127847571 | 12784757 | 5 | C | LEDERFOLINE | LEUCOVORIN CALCIUM | 1 | 25 MG, QD | 0 | 25 | MG | QD | ||||||||
| 127847571 | 12784757 | 6 | C | LEDERFOLINE | LEUCOVORIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 127847571 | 12784757 | 7 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 127847571 | 12784757 | 8 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 127847571 | 12784757 | 9 | C | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | UNK | 0 | |||||||||||
| 127847571 | 12784757 | 10 | C | TAZOCILLINE | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | UNK | 0 | |||||||||||
| 127847571 | 12784757 | 11 | C | TOPALGIC /00599202/ | TRAMADOL | 1 | 0 | ||||||||||||
| 127847571 | 12784757 | 12 | C | OXYCODONE | OXYCODONE | 1 | 0 | ||||||||||||
| 127847571 | 12784757 | 13 | C | SERESTA | OXAZEPAM | 1 | UNK | 0 | |||||||||||
| 127847571 | 12784757 | 14 | C | IMOVANE | ZOPICLONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127847571 | 12784757 | 1 | HIV infection |
| 127847571 | 12784757 | 2 | HIV infection |
| 127847571 | 12784757 | 3 | Ischaemic cerebral infarction |
| 127847571 | 12784757 | 5 | Vitamin supplementation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127847571 | 12784757 | OT |
| 127847571 | 12784757 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127847571 | 12784757 | Alanine aminotransferase increased | |
| 127847571 | 12784757 | Aspartate aminotransferase increased | |
| 127847571 | 12784757 | Blood alkaline phosphatase increased | |
| 127847571 | 12784757 | Blood bilirubin increased | |
| 127847571 | 12784757 | Cholestasis | |
| 127847571 | 12784757 | Gamma-glutamyltransferase increased | |
| 127847571 | 12784757 | Hepatocellular injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127847571 | 12784757 | 1 | 20160810 | 20160829 | 0 | |
| 127847571 | 12784757 | 2 | 20160810 | 20160829 | 0 | |
| 127847571 | 12784757 | 3 | 20160811 | 20160829 | 0 | |
| 127847571 | 12784757 | 4 | 20160725 | 20160829 | 0 | |
| 127847571 | 12784757 | 6 | 20160717 | 0 | ||
| 127847571 | 12784757 | 9 | 20160717 | 0 | ||
| 127847571 | 12784757 | 13 | 20160717 | 0 | ||
| 127847571 | 12784757 | 14 | 20160717 | 0 |